MARK2 regulates chemotherapeutic responses through class IIa HDAC-YAP axis in pancreatic cancer
Yongji Zeng, Ling Yin, Jiuli Zhou, Renya Zeng, Yi Xiao, Adrian R. Black, Tuo Hu, Pankaj K. Singh, Feng Yin, Surinder K. Batra, Fang Yu, Yuanhong Chen, Jixin Dong
Topics & Concepts
PaclitaxelCancer researchBiologyKinomeDownregulation and upregulationCytotoxicityMitosisCancerPhosphorylationCell biologyIn vitroBiochemistryGeneticsGeneHippo pathway signaling and YAP/TAZMicrotubule and mitosis dynamicsKruppel-like factors research